Dr Reddy's, FDC recall generic medications in US over manufacturing issues

Q: How long will it take to read this news story?

The story "Dr Reddy&#039;s, FDC recall generic medications in US over manufacturing issues" has 397 words across 18 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Dr Reddy&#039;s, FDC recall generic medications in US over manufacturing issues" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 112 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23624925</li><li>URL: https://beamstart.com/news/dr-reddys-fdc-recall-generic-17318247991654</li></ul>

Business Standard Logo Business Standard 5h ago

Dr Reddy's, FDC recall generic medications in US over manufacturing issues - Business Standard

Quick Summary:

As per the latest Enforcement Report by Food and Drug Administration (USFDA), the US-based subsidiary of Dr Reddy's Laboratories is recalling multiple strengths of Morphine Sulfate extended-release tablets in the US.

As per the USFDA, Princeton-based Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to "Failed Impurities/Degradation Specification".

Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according to the US health regulator.